The deubiquitinating enzyme UCHL1 is a favorable prognostic marker in neuroblastoma as it promotes neuronal differentiation

Table 1 The association between UCHL1 expression with clinical pathologic characteristics in the TMA cohort

Clinical pathologic characteristics	Case No.	UCHL1 expression		P
Clinical pathologic characteristics	Case No.	low	high	P
Total cases		33	31
Gender
Male	35	17	18	P = 0.5989
Female	29	16	13
Age at diagnosis
< 18 months	20	11	9	P = 0.7106
> 18 months	44	22	22
stage
1, 2, 3	41	20	21	P = 0.3535
4, 4S	23	13	10
Primary site
Retroperitoneum	29	15	14	P^a = 0.9312
Postmediastinum	8	4	4
NA	27	14	13
Bone marrow metastasis
Positive	7	3	4	P^b = 0.6054
Negative	26	14	12
NA	31	16	15

NA Not available. Analysis by chi-square criterion test
^aDenotes significant difference between retroperitoneum and postmediastinum
^bDenotes significant difference between positive and negative bone marrow metastasis

ISSN: 1756-9966